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Abstract
Early glottic squamous cell carcinoma (Tis–T1) is a highly treatable 
disease by any of the main treatment methods available. Carbon 
dioxide transoral laser microsurgery (TLM) and radiotherapy (RT) 
are considered the two main treatment methods for early glottic 
carcinomas. However, the both treatment strategies have advantages 
and disadvantages. TLM is by many authors described as the gold 
standard mainly due to better overall survival, shorter hospitalization, 
lower morbidity, and arguably better functional outcomes compared 
to those of RT. Furthermore, TLM as a primary treatment strategy 
leaves open all treatment options in patients with recurrent disease. 
Introduction:
Brief History of CO2 Laser of the Larynx
The development of new equipment and techniques 
inspired Prof. Geza Jako to apply the CO2 laser 
energy in the larynx of cadavers at the beginning 
of the 1970s. This led to publishing a study about 
the use of a carbon dioxide laser in the larynx of 13 
dogs in 1972 [1].
In the same year, Strong and Jako were the first to 
publish the use of CO2 laser, in combination
with microscopic visualization and direct laryngos-
copy, for the surgical treatment of benign laryngeal 
lesions in human patients [2]. Annyas, Steiner, 
Eckel are well know as they all have contributed to 
the beginning of the spread of the technique across 
the continent [3].
Laryngeal cancer is the second most common can-
cer in the upper aerodigestive tract. Approximately 
95% of laryngeal cancers are squamous cell carci-
nomas (SCC), and a significant majority occur in 
patients between 60 and 70 years old [4].
Early cancer of the glottis refers to a cancer that 
has not spread to adjacent spaces of the larynx and 
corresponds to the stages Tis, T1, and T2 (AJCC/
UICC TNM, 8th edition) [5].  
Patients present with hoarseness as the first symp-
tom of cancer of glottis. The early diagnosis is 
quite relevant, since advanced lesions require more 
aggressive treatment modalities.
The extent of the neoplasm can be evaluated by 
using imaging examinations, such as computed 
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tomography (CT) and magnetic resonance imag-
ing (MRI), particularly in cases in which all limits 
cannot be determined with direct laryngoscopy. 
However, laryngoscopy remains the most import-
ant examination for diagnosing and staging of early 
cancer of the glottis [3].
Treatment of early stage laryngeal cancer devel-
oped over the last five decades especially with the 
transition from the classic open surgical resection 
methods to the less aggressive and more functional 
endoscopic approach. Nowadays treatment options 
show good local control, high laryngectomy-free 
survival rates and overall high success rates 80%–
90%. [6]
An important goal of initial treatment of early 
glottic squamous cell carcinoma (Tis–T2), other 
than survival, is functional organ preservation 
by achieving local control while avoiding total 
laryngectomy. When choosing treatment strate-
gies, the secondary parameters such as func-
tional outcome (voice, swallowing etc.), mor-
bidity, and quality of life also play a large role. 
Different types of treatment modalities, such as 
transoral laser microsurgery (TLM), radiotherapy 
(RT), or open partial laryngectomy (OPL) can be 
considered for treatment options [7].
Series of studies revealed best results with TLM 
because of its low management costs, reduced hos-
pitalization time, and good oncological and func-
tional results, with low complication rates and less 
severe complications when compared to the other 
techniques [8, 9]. 
RT offers similar oncological and functional out-
comes, but higher costs, prolonged time of treat-
ment, mucosal damage, and long-term side effects 
such as xerostomia [10].
Discussion
Initial treatment of early glottic squamous cell car-
cinoma aims at various goals as overall survival, 
laryngeal preservation by achieving local control 
while avoiding total laryngectomy. 
Both TLM and RT offer similar outcomes as treat-
ment options for early glottic carcinomas. The 
selection of treatment strategy depends not only 
overall survival rate but on functional outcomes 
as voice, swallowing and quality of life. Due to 
the lack of randomized controlled trials accessing 
this issue, it is hard to say which of the therapeutic 
options gives better outcomes. 
Overall survival and laryngeal 
preservation.
A recent meta-analysis from 2019, published in 
Journal of Otolaryngology – Head and Neck Sur-
gery, included 1987 patients from 16 cohort stud-
ies. Vaculic et al. demonstrated that TLM was 
associated with better outcomes in terms of overall 
survival, disease-specific survival and laryngeal 
preservation [11]. 
Mo and co-authors published a meta-analysis in 
2016, which showed significantly improved overall 
survival of patients with T1 glottic carcinoma in the 
TLM (p=0.04) and significantly better laryngeal 
preservation. As a limitation of the study authors 
point to the fact, that some studies did not have 
clear indications for inclusion of patients in TLM 
or RT treatment [12].
Gioacchini and co-authors concluded that there are 
no significant differences in terms of survival rate 
in both groups [13].
An older meta-analysis from 2009, which is based 
on over 7600 patients, favors the TLM in compar-
ison to RT treatment for overall survival. Higgins 
and co-authors did not find no differences in local 
control and laryngectomy-free survival as well as 
for the voice [14].
Fuctional outcomes –  
voice and quality of life
Greulich et al. published a meta-analysis in 2015, 
which included 207 patients receiving RT and 
155 patients with receiving TLM from 8 research 
papers T1 glottic carcinoma. The meta-analysis 
focused on VHI (Voice Handicapped Index), which 
evaluates the voice outcomes after RT and TLM 
treatment. There was no statistical significant dif-
ference between subjective voice outcomes follow-
ing XRT versus surgery for treatment of T1 glottic 
carcinoma. [15]
Guangyuan Du et al. punished a meta-analysis also 
in 2015, which included 368 patients receiving 
RT and 440 patients with receiving TLM from 13 
articles. The meta-analysis focused on VHI (Voice 
Handicapped Index), which evaluates the voice 
outcomes after RT and TLM treatment. Authors 
investigated the acoustic voice analyses, which 
included fundamental frequency, shimmer and 
jitter. Authors did not registered any differences in 
the jitter and shimmer qualities, but indicated that 
TLMR has advantage in the fundamental frequency 
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in comparison to the RT [16].
Lee and co-authors published a meta-analysis of 
acoustic parameters in 744 patients with early 
glottic carcinoma (T1 and T2), which showed 
significant differences in jitter, shimmer, noise to 
harmonic ratio with more favorable values in the 
RT group than those in the TLMS group [17].
Conclussion 
RT and TLM are two viable options for treatment 
of early glottic cancer. Both have their advantages 
and limitations. Although TLM seems to have an 
advantage in comparison to RT therapy in patients 
with T1 carcinoma, management of those patients 
should be individualized, according to surgical 
risk factors, advanced stage, deeper layers, or in 
cases of refusal of surgical intervention. Prospec-
tively randomized controlled, multicenter studies 
are required to further prove the efficacy of initial 
TLM over initial RT therapy. 
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